Tesofensine is a research compound originally developed for the treatment of neurodegenerative conditions such as Alzheimer’s disease and Parkinson’s disease. During clinical trials, researchers observed a significant weight loss effect, which shifted its focus toward being investigated as a potential anti-obesity treatment.
How It Works
Tesofensine belongs to the class of triple monoamine reuptake inhibitors (TRIs). It works by blocking the reuptake of three key neurotransmitters in the brain:
-
Serotonin (5-HT) – regulates mood and satiety.
-
Noradrenaline (NA) – influences energy expenditure and alertness.
-
Dopamine (DA) – impacts reward and motivation.
By increasing the levels of these neurotransmitters, Tesofensine helps suppress appetite, reduce food cravings, and boost metabolism, leading to reduced calorie intake and enhanced fat loss.
Benefits Observed in Research
-
Significant weight reduction compared to placebo in clinical trials.
-
Appetite suppression and lower daily calorie consumption.
-
Improved metabolic markers such as blood sugar and cholesterol levels in some studies.
-
Enhanced energy and focus, as a result of its action on dopamine and noradrenaline.
Potential Side Effects
Like many compounds that act on neurotransmitters, Tesofensine may cause side effects. The most commonly reported include:
-
Dry mouth
-
Insomnia or difficulty sleeping
-
Increased heart rate or blood pressure
-
Mild gastrointestinal issues (nausea, constipation)
Close monitoring is advised during use, especially in individuals with cardiovascular concerns.
Current Status
Tesofensine is still considered an experimental compound and is not yet approved for general medical use. Research continues to evaluate its safety, effectiveness, and long-term benefits as a weight management solution.




Reviews
There are no reviews yet.